Finance

Lists
002252:SHE
Shanghai RAAS Blood Products Co Ltd
CNÂ¥4.92
0.00%
(0.00) 1D
Sep 4, 3:04:06 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002252...
Open
CNÂ¥4.92
High
CNÂ¥4.98
Low
CNÂ¥4.92
Mkt. cap
32.44B
Avg. vol.
50.76M
Volume
32.30M
Dividend
0.98%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 24, 2026
P/E ratio
26.87
52-wk high
CNÂ¥6.97
52-wk low
CNÂ¥4.18
EPS
CNÂ¥0.18
Shares outstanding
6.59B
No. of employees
4K
Open
CNÂ¥4.92
High
CNÂ¥4.98
Low
CNÂ¥4.92
Mkt. cap
32.44B
Avg. vol.
50.76M
Volume
32.30M
Dividend
0.98%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 24, 2026
P/E ratio
26.87
52-wk high
CNÂ¥6.97
52-wk low
CNÂ¥4.18
EPS
CNÂ¥0.18
Shares outstanding
6.59B
No. of employees
4K
About Shanghai RAAS Blood Products Co Ltd
CEO-
Employees4.04K
FoundedOct 29, 1988
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.14B
1.26B
1.51B
1.70B
Cost of goods sold
1.35B
828.13M
942.79M
1.15B
Cost of revenue
1.35B
828.13M
942.79M
1.15B
Research and development expenses
48.32M
73.79M
44.42M
89.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
236.38M
241.85M
182.57M
196.48M
Operating expense
307.00M
308.55M
241.16M
306.95M
Total operating expenses
1.66B
1.14B
1.18B
1.45B
Operating income
482.77M
120.45M
325.54M
246.49M
Other non operating income
11.10M
-21.93M
917.46K
10.30M
EBT including unusual items
513.97M
181.81M
375.95M
425.90M
EBT excluding unusual items
567.01M
191.26M
381.36M
418.35M
Income tax expense
73.31M
75.53M
60.12M
80.51M
Effective tax rate
14.26%
41.55%
15.99%
18.90%
Other operating expenses
7.61M
16.06M
13.04M
12.14M
Net income
440.85M
106.27M
315.83M
345.39M
Net profit margin
20.61%
8.45%
20.92%
20.32%
Earnings per share
0.06
0.02
-
-
Interest and investment income
88.78M
96.72M
9.88M
239.80M
Interest expense
-17.35M
-20.78M
-20.81M
-20.03M
Net interest expenses
71.43M
75.95M
-10.93M
219.77M
Depreciation and amortization charges
-
-
-
-
EBITDA
532.66M
175.88M
380.96M
309.55M
Gain or loss from assets sale
48.61K
-21.16M
-
-2.18M
AI content may include mistakes. Learn more
Google apps